RMDB: An Integrated Database of Single-cytosine-resolution DNA Methylation in Oryza Sativa

2019 ◽  
Vol 14 (6) ◽  
pp. 524-531
Author(s):  
Tiansheng Zhu ◽  
Jihong Guan ◽  
Hui Liu ◽  
Shuigeng Zhou

Background: Previous studies have revealed that DNA methylation plays a crucial role in eukaryotic growth and development via involvement in the regulation of gene expression and chromosomal instability. With the advancement of biotechnology, next-generation sequencing (NGS) is emerging as a popular method to explore the functions of DNA methylation, and an increasing number of genome-scale DNA methylation datasets have been published. Several DNA methylation databases, including MethDB, NGSmethDB and MENT have been developed for storing and analyzing the DNA methylation data. However, no public resource dedicated to DNA methylation of Oryza sativa is available to date. Methods & Results: We built a comprehensive database (RMDB) for integration and analysis of DNA methylation data of Oryza sativa. A couple of functional modules were developed to identify the connections between DNA methylation and phenotypes. Moreover, rich graphical visualization tools were employed to facilitate data presentation and interpretation. Conclusion: RMDB is an integrated database dedicated to rice DNA methylation. To the best of our knowledge, this is the first integrated rice DNA methylation database. We believe that RMDB will be helpful to understand the epigenetic mechanisms of Oryza sativa. RMDB is freely available at http://admis.fudan.edu.cn/rmdb.

2015 ◽  
Vol 16 (Suppl 15) ◽  
pp. P7 ◽  
Author(s):  
Akhilesh Kaushal ◽  
Hongmei Zhang ◽  
Wilfried JJ Karmaus ◽  
Julie SL Wang

Author(s):  
Л.А. Капснер ◽  
М.Г. Завгородний ◽  
С.П. Майорова ◽  
Ф. Халлер ◽  
И.Н. Лебедев ◽  
...  

Высокоточный количественный анализ профилей метилирования ДНК в опухолях лежит в основе эпигенетической диагностики, а также необходим для более полного и адекватного понимания молекулярных механизмов опухолеобразования. Тем не менее, результаты анализа метилирования ДНК часто содержат экспериментальные отклонения разного происхождения. Ранее мы предложили алгоритм для эффективной корректировки данных, содержащих экспериментальное искажение, однако, решение данных уравнений вручную или с использованием электронных таблиц не является оптимальным подходом. В данной работе мы представляем приложения BiasCorrector и MethCorrector, имплементирующие алгоритм в виде R-пакета и программы на языке Ruby, соответственно. Разработанные программы обеспечивают детекцию, анализ и устранение экспериментальных отклонений для каждого CpG-динуклеотида. Функционирование приложений было протестировано с использованием данных метилирования ДНК, полученных с помощью трёх разных технологий анализа: бисульфитного пиросеквенирования, высокопроизводительного бисульфитного секвенирования и гибридизационного анализа на олигонуклеотидных ДНК-чипах. Обе программы способны эффективно устранять экспериментальные отклонения безотносительно к исследуемому региону, числу CpG-динуклеотидов, методу эпигенетического анализа, а также природе искажений. Accurate quantification of DNA methylation in cancer is a prerequisite for epigenetic-based diagnostics as well as the mechanistic understanding of tumour development. Still, the results of DNA methylation analysis are often prone to experimental biases of different origin. Since that thorough optimisation of the experimental conditions - a possibility to prevent biases - has serious limitations, particularly if many loci are analysed in parallel, we have earlier developed a universal process for correcting biased DNA methylation data irrespective of the loci that are interrogated. Its implementation required multiple manual steps, for example, solving the respective equations by using electronic tables, thereby increasing the risk of introducing errors and necessitating automation. Here, we present web-applications BiasCorrector and MethCorrector that implement our algorithm in the open-source programming languages “R” or Ruby, respectively. The software offers a graphical user interface (GUI) to accommodate also researchers without prior programming skills. Three common technologies - bisulphite pyrosequencing and next generation sequencing as well as oligonucleotide microarrays - were used to comprehensively test the correct operation of the applications. We demonstrate the accuracy of BiasCorrector’s performance and reveal PCR- and post-PCR biases that contribute to the total experimental deviation in a technology-specific manner. Both programmes effectively eliminate biases regardless of their nature, locus, the number of interrogated methylation sites, and the detection method. They are of interest as user friendly tools for epigenetic studies and are freely available https://biascorrector.diz.uk-erlangen.de/ and http://approximation.herokuapp.com/


2021 ◽  
pp. 109352662110136
Author(s):  
Petros Giannikopoulos ◽  
David M Parham

For the past 40 years, progress in rhabdomyosarcoma (RMS) has been focused on understanding its molecular basis and characterizing the mutations that drive its tumorigenesis and progression. Genetic predisposition to RMS has allowed discovery of key genetic pathways and driver mutations. Subclassification of RMS into embryonal (ERMS) and alveolar (ARMS) subtypes has shifted from histology to PAX-FOXO1 fusion status, and new driver mutations have been found in spindle cell RMS. Comprehensive molecular profiling leveraging genome-scale next-generation sequencing (NGS) indicates that the RAS/RAF/PI3K axis is mutated in the majority of ERMS and modulated by downstream effects of PAX-FOXO1 fusions in ARMS. Because of the continued poor outcome of high-risk RMS, a variety of molecular targets have been or are now being tested in current or recent therapy trials. New techniques such as single cell sequencing, spatial multi-omics, and CRISPR/Cas9 genome editing offer potential for further discovery, but a need for clinically annotated specimens persists.


Sign in / Sign up

Export Citation Format

Share Document